LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and skin care products. The company offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio, a line of energy drink mixes; Omega+, a fish oil dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to treat oxidative stress in dogs. It also provides skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, and micro-lift serums; and Hair Care System under the TrueScience brand name. The company sells its products through a direct sales model, as well as a network of independent distributors in the United States, Japan, Hong Kong, Australia, Canada, Mexico, Thailand, the United Kingdom, the Netherlands, Germany, Spain, and Taiwan. LifeVantage Corporation is headquartered in Sandy, Utah.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Phone801-432-9000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$225.96 million
Profitability
Miscellaneous
Employees220
Next Earnings Date5/6/2020 (Estimated)
OptionableOptionable
LifeVantage (NASDAQ:LFVN) Frequently Asked Questions
What is LifeVantage's stock symbol?
LifeVantage trades on the NASDAQ under the ticker symbol "LFVN."
How were LifeVantage's earnings last quarter?
LifeVantage Corp (NASDAQ:LFVN) issued its earnings results on Tuesday, January, 28th. The company reported $0.31 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.15. The company earned $61.24 million during the quarter. LifeVantage had a net margin of 5.12% and a return on equity of 44.94%. View LifeVantage's Earnings History.
When is LifeVantage's next earnings date?
What guidance has LifeVantage issued on next quarter's earnings?
LifeVantage updated its FY 2020
After-Hours earnings guidance on Tuesday, January, 28th. The company provided EPS guidance of 0.74-0.79 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.70. The company issued revenue guidance of $235-245 million, compared to the consensus revenue estimate of $245 million.
Has LifeVantage been receiving favorable news coverage?
News coverage about LFVN stock has been trending somewhat positive recently, InfoTrie reports. The research firm identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. LifeVantage earned a media sentiment score of 1.2 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for LifeVantage.
Are investors shorting LifeVantage?
LifeVantage saw a decline in short interest in the month of January. As of January 31st, there was short interest totalling 667,000 shares, a decline of 10.9% from the January 15th total of 748,500 shares. Based on an average daily trading volume, of 79,400 shares, the days-to-cover ratio is currently 8.4 days. Approximately 5.3% of the company's stock are sold short. View LifeVantage's Current Options Chain.
Who are some of LifeVantage's key competitors?
Some companies that are related to LifeVantage include Radius Health (RDUS), Stoke Therapeutics (STOK), Amphastar Pharmaceuticals (AMPH), Dova Pharmaceuticals (DOVA), Rhythm Pharmaceuticals (RYTM), Collegium Pharmaceutical (COLL), CannTrust (CNTTF), ImmunoGen (IMGN), Homology Medicines (FIXX), Arcus Biosciences (RCUS), Retrophin (RTRX), Aprea Therapeutics (APRE), DiaMedica Therapeutics (DMCAF), Frequency Therapeutics (FREQ) and Endonovo Therapeutics (ENDV).
What other stocks do shareholders of LifeVantage own?
Who are LifeVantage's key executives?
LifeVantage's management team includes the folowing people:
- Mr. Darren Jay Jensen, Pres, CEO & Director (Age 50)
- Mr. Steven R. Fife, Chief Financial Officer (Age 58)
- Mr. Charles J. Wach, Chief Operating Officer (Age 57)
- Mr. Kevin McMurray, Gen. Counsel
- Mr. Ryan Goodwin, Chief Marketing Officer (Age 42)
Who are LifeVantage's major shareholders?
LifeVantage's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (8.00%), Acadian Asset Management LLC (3.78%), State Street Corp (1.74%), AJO LP (1.62%), Geode Capital Management LLC (1.49%) and Jacobs Levy Equity Management Inc. (1.14%). Company insiders that own LifeVantage stock include Darren Jay Jensen, Garry Paul Mauro, Justin Rose and Raymond B Greer. View Institutional Ownership Trends for LifeVantage.
Which institutional investors are selling LifeVantage stock?
LFVN stock was sold by a variety of institutional investors in the last quarter, including Oxford Asset Management LLP, AXA, California Public Employees Retirement System, Bank of New York Mellon Corp, Wedge Capital Management L L P NC, Connor Clark & Lunn Investment Management Ltd., AJO LP and Strs Ohio. Company insiders that have sold LifeVantage company stock in the last year include Darren Jay Jensen and Justin Rose. View Insider Buying and Selling for LifeVantage.
Which institutional investors are buying LifeVantage stock?
LFVN stock was acquired by a variety of institutional investors in the last quarter, including Cadence Capital Management LLC, Acadian Asset Management LLC, Renaissance Technologies LLC, Los Angeles Capital Management & Equity Research Inc., Mackay Shields LLC, Geode Capital Management LLC, Russell Investments Group Ltd. and New York State Common Retirement Fund. Company insiders that have bought LifeVantage stock in the last two years include Garry Paul Mauro and Raymond B Greer. View Insider Buying and Selling for LifeVantage.
How do I buy shares of LifeVantage?
Shares of LFVN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is LifeVantage's stock price today?
One share of LFVN stock can currently be purchased for approximately $14.05.
How big of a company is LifeVantage?
LifeVantage has a market capitalization of $201.74 million and generates $225.96 million in revenue each year. The company earns $7.43 million in net income (profit) each year or $0.59 on an earnings per share basis. LifeVantage employs 220 workers across the globe.View Additional Information About LifeVantage.
What is LifeVantage's official website?
How can I contact LifeVantage?
LifeVantage's mailing address is 9785 S. MONROE STREET SUITE 400, SANDY UT, 84070. The company can be reached via phone at 801-432-9000 or via email at [email protected]
MarketBeat Community Rating for LifeVantage (NASDAQ LFVN)
MarketBeat's community ratings are surveys of what our community members think about LifeVantage and other stocks. Vote "Outperform" if you believe LFVN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LFVN will underperform the S&P 500 over the long term. You may vote once every thirty days.
